Editors' pick 2011

British Journal of Clinical Pharmacology

Volumn 73, Issue 1, 2012, Pages 4-8

  Somogyi, Andrew ^a   Loke, Yoon K ^b   Ferro, Albert ^c   Lewis, Lionel D ^d   Cohen, Adam F ^e   Ritter, James M ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANTHROQUINONE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; DAUNORUBICIN; DOCETAXEL; ENDOXIFEN; FENFLURAMINE; GEMCITABINE; N BISDESMETHYLSIBUTRAMINE; NICOTINE; PHENOLPHTHALEIN; QUINONE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; TAMOXIFEN; THROMBIN INHIBITOR; TICAGRELOR; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; AREA UNDER THE CURVE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HYPERSENSITIVITY; DRUG INTERACTION; DRUG METABOLISM; DRUG SAFETY; DRUG SUBSTITUTION; EDITORIAL; ESOPHAGUS CARCINOMA; HUMAN; PATIENT SAFETY; PHARMACOGENETICS; PRESCRIPTION; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 83155176080     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.04144.x     Document Type: Editorial

References (26)

1. Tang MHY, Chen SPL, Ng SW, Chan AYW, Mak TWL. Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected. Br J Clin Pharmacol 2011; 71: 250-3.
2. Polasek TM, Lin FPY, Miners JO, Doogue MP. Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment. Br J Clin Pharmacol 2011; 71: 727-7363.
3. Lim JSL, Chen XA, Singh O, Yap YS, Ng RCH, Wong NS, Wong M, Lee EJD, Chowbay B. Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. Br J Clin Pharmacol 2011; 71: 737-50.
4. Chang C-B, Chen J-H, Wen C-J, Kuo H-K, Lu I-S, Chiu L-S, Wu S-C, Chan D-C. Potentially inappropriate medications in geriatric out-patients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 2011; 72: 482-9.
5. Baker E, Roberts AP, Wilde K, Walton H, Suri S, Rull G, Webb A. Development of a core drug list towards improving prescribing education and reducing errors in the UK. Br J Clin Pharmacol 2011; 71: 190-8.
6. Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LTW. Road traffic accidents and psychotropic medication use in the Netherlands: a case-control study. Br J Clin Pharmacol 2011; 72: 505-13.
7. Czarnetzki C, Schiffer E, Lysakowski C, Haller G, Bertrand D, Tramèr MR. Transcutaneous nicotine does not prevent postoperative nausea and vomiting: a randomized controlled trial. Br J Clin Pharmacol 2011; 71: 383-90.
8. Bailey DG, Malcolm JAO, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998; 46: 101-10.
9. Hanley MJ, Cancalon P, Widmer WW, Greenblatt DJ. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol 2011; 7: 267-86.
10. Farkas D, Greenblatt DJ. Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol 2008; 4: 381-93.
11. Bailey DG. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol 2010; 70: 645-55.
12. Reddy P, Ellington D, Zhu Y, Zdrojewski I, Parent SJ, Harmatz JS, Derendorf H, Greenblatt DJ, Browne K Jr. Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily. Br J Clin Pharmacol 2011; 72: 434-41.
13. Lilja JJ, Kivistö KT, Neuvonen PJ. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin Pharmacol Ther 1999; 66: 118-27.
14. Fukazawa I, Uchida N, Uchida E, Yasuhara H. Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese. Br J Clin Pharmacol 2004; 57: 448-55.
15. Valenzuela B, Rebollo J, Pérez T, Brugarolas A, Pérez-Ruixo JJ. Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report. Br J Clin Pharmacol 2011; 72: 978-81.
16. van Zuylen L, Verweij J, Nooter K, Brouwer E, Stoter G, Sparreboom A. Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans. Clin Cancer Res 2000; 6: 2598-603.
17. Tapaninen T, Neuvonen PJ, Niemi M. Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren. Br J Clin Pharmacol 2011; 71: 718-26.
18. Roth M, Obaidat A, Hagenbuch B. OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 2011; 10.1111/j.1476-5381.2011.01724.x. [Epub ahead of print].
19. Aronson JK. Littluns and biguns. Br J Clin Pharmacol 2004; 58: 117-8.
20. Lindkvist J, Airaksinen M, Kaukonen AM, Klaukka T, Hoppu K. Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007. Br J Clin Pharmacol 2011; 71: 929-35.
21. Neubert A, Hsia Y, de Jong-van den Berg LTW, Janhsen K, Glaeske G, Furu K, Kieler H, Nørgaard M, Clavenna A, Wong ICK. Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries. Br J Clin Pharmacol 2011; 72: 969-77.
22. Mahmood I. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model? Br J Clin Pharmacol 2011; 71: 88-94.
23. Foissac F, Blanche S, Dollfus C, Hirt D, Firtion G, Laurent C, Treluyer J-M, Urien S. Population pharmacokinetics of atazanavir/r in HIV-1 infected children and adolescents. Br J Clin Pharmacol 2011; 72: 940-7.
24. Adam de Beaumais T, Fakhoury M, Medard Y, Azougagh S, Zhang D, Yakouben K, Jacqz-Aigrain E. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br J Clin Pharmacol 2011; 71: 575-84.
25. Yanagimachi M, Naruto T, Hara T, Kikuchi M, Hara R, Miyamae T, Imagawa T, Mori M, Kaneko T, Morita S, Goto H, Yokota S. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Br J Clin Pharmacol 2011; 71: 237-43.
26. Chiney MS, Schwarzenberg SJ, Johnson LA. Altered xanthine oxidase and N-acetyltransferase activity in obese children. Br J Clin Pharmacol 2011; 72: 109-15.